| Financial Year |
March 31 2023 |
| Monetary Funds |
75,292,061.65 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
225,994,994.06 |
| Accounts Receivable |
245,850,855.75 |
| Advances to Suppliers |
103,632,632.41 |
| Other Receivables |
192,532,136.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
230,132,541.30 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
51,167,267.81 |
| Total Current Assets |
1,140,871,333.82 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
913,297,100.44 |
| Under-construction Projects |
47,762,315.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
104,362,240.77 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
9,983,106.14 |
| Deferred Income Tax Assets |
90,013,576.27 |
| Other Non-Current Assets |
6,510,002.00 |
| Sub-Total of Non-Current Assets |
1,171,928,341.13 |
| Total Assets |
2,312,799,674.95 |
| Short-Term Loans |
131,366,916.01 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
125,086,463.98 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
55,644,949.04 |
| Taxes Payable |
13,396,751.89 |
| Interest Payable |
5,043,439.64 |
| Dividend Payable |
-- |
| Other payables |
29,709,881.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,000,000.00 |
| Other Current Liabilities |
143,253,766.50 |
| Sub-Total of Current Liabilities |
563,051,190.11 |
| Long-term Loans |
446,187,091.73 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
125,168,755.04 |
| Special Payable |
-- |
| Estimatied Liabilities |
114,622,226.04 |
| Deferred Income Tax Liabilities |
18,499,694.98 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
709,448,184.82 |
| Total Liabilities |
1,272,499,374.93 |
| Paid-In Capital(Or Share Stock) |
985,432,777.00 |
| Capital Surplus |
1,888,067,876.25 |
| Surplus Reserve |
97,030,369.29 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,930,611,806.90 |
| Minority Stockholder's Interest |
218,241.03 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,040,082,058.99 |
| Owner's Equity（Stockholder's Equity） |
1,040,300,300.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,312,799,674.95 |
